Juttmann J R, Visser T J, Buurman C, de Kam E, Birkenhäger J C
Br Med J (Clin Res Ed). 1981 Apr 25;282(6273):1349-52. doi: 10.1136/bmj.282.6273.1349.
Serum concentrations of 25-hydroxycholecalciferol (25-OHD), 24,25-dihydroxycholecalciferol (24,25-(OH)2D), and 1,25-dihydroxycholecalciferol (1,25-(OH)2D) were measured at monthly intervals throughout the year in eight normal subjects. 25-OHD was measured by competitive protein-binding assay after Sephadex LH 20 chromatography, 24,25-(OH)2D by competitive protein-binding assay after Sephadex LH 20 and high-pressure chromatography, and 1,25-(OH)2D by radioimmunoassay after the same separation procedure as for 24,25-(OH)2D. A seasonal variation, apparently dependent on exposure to ultraviolet light, was found for all three metabolites. A study in six other normal subjects showed that there was no diurnal rhythm in any of the metabolites. Oral administration of 2 microgram 1,25-(OH)2D caused a sharp rise in serum concentrations of 1,25-(OH)2D and no change in the concentrations of the two other metabolites, but by 12 hours the 1,25-(OH)2D concentration had returned to the basal value. The concentrations of all three metabolites studied vary according to the season. Thus to interpret these concentrations in any subject the normal range for the particular season must be referred to.
全年每月对8名正常受试者测定血清中25-羟胆钙化醇(25-OHD)、24,25-二羟胆钙化醇(24,25-(OH)₂D)和1,25-二羟胆钙化醇(1,25-(OH)₂D)的浓度。25-OHD通过Sephadex LH 20柱层析后的竞争性蛋白结合法测定,24,25-(OH)₂D通过Sephadex LH 20柱层析和高压层析后的竞争性蛋白结合法测定,1,25-(OH)₂D采用与24,25-(OH)₂D相同的分离方法后的放射免疫法测定。发现所有这三种代谢物均有明显依赖于紫外线暴露的季节性变化。对另外6名正常受试者的研究表明,任何一种代谢物均无昼夜节律。口服2微克1,25-(OH)₂D导致血清中1,25-(OH)₂D浓度急剧升高,而另外两种代谢物的浓度无变化,但12小时后1,25-(OH)₂D浓度恢复至基础值。所研究的所有三种代谢物的浓度均随季节变化。因此,要解释任何受试者的这些浓度,必须参考特定季节的正常范围。